treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine , cyclophosphamide , methotrexate , and 5-fluorourcil ( hexa-caf ) in patients with and without previous treatment .
C0010583
cyclophosphamide
C0062594
hexa-caf